Public research preview
Gilbert Cisneros, Representative disclosure: ica BridgeBio Pharma, Inc. - Common Stock (BBIO)
Disclosed a buy transaction in ica BridgeBio Pharma, Inc. - Common Stock (BBIO). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 8 May 2026, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 9 days
Timeline
Transaction date
29 Apr 2026
Public disclosure
8 May 2026
Now
Tracked today
Filing delay: 9 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 9 Jun 2026
Stock path
BBIO from pre-transaction context through latest close.
Bought
29 Apr 2026 · 70,94 USD
- Observed transaction close
- 70,94
- Observed disclosure close
- 67,39
- Observed latest close
- 67,68
- Pre-disclosure move
- -5.0%
- Post-disclosure move
- +0.4%
- Market-adjusted move
- +0.4%
Why Copy Window is Be careful chasing
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 8 May 2026, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%